KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Taxes (2016 - 2025)

Historic Current Taxes for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$437.1 million.

  • Gsk's Current Taxes rose 4077.37% to -$437.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$437.1 million, marking a year-over-year increase of 4077.37%. This contributed to the annual value of -$898.6 million for FY2024, which is 24449.44% down from last year.
  • Latest data reveals that Gsk reported Current Taxes of -$437.1 million as of Q3 2025, which was up 4077.37% from -$775.1 million recorded in Q2 2025.
  • Gsk's Current Taxes' 5-year high stood at $659.2 million during Q4 2021, with a 5-year trough of -$988.4 million in Q3 2021.
  • Over the past 5 years, Gsk's median Current Taxes value was -$574.5 million (recorded in 2021), while the average stood at -$448.8 million.
  • Its Current Taxes has fluctuated over the past 5 years, first skyrocketed by 8461.9% in 2022, then plummeted by 24539.75% in 2024.
  • Gsk's Current Taxes (Quarter) stood at $659.2 million in 2021, then decreased by 16.19% to $552.4 million in 2022, then increased by 12.33% to $620.6 million in 2023, then plummeted by 245.4% to -$902.3 million in 2024, then surged by 51.56% to -$437.1 million in 2025.
  • Its last three reported values are -$437.1 million in Q3 2025, -$775.1 million for Q2 2025, and -$791.0 million during Q1 2025.